动物模型与实验医学(英文)2023，Vol.6Issue(3)：P.245-254,10.DOI:10.1002/ame2.12330
Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer
Yumin Wei 1Liping Zhang 1Chao Wang 1Zefeng Li 2Mingjie Luo 3Guomin Xie 1Xingjiu Yang 1Mengyuan Li 1Shuyue Ren 1Dongbing Zhao 2Ran Gao 1Jia-Nan Gong1
作者信息
- 1. National Human Diseases Animal Model Resource Center,The Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,China NHC Key Laboratory of Human Disease Comparative Medicine,Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases,Beijing,China Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases,Beijing,China
- 2. Department of Pancreatic and Gastric Surgical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
- 3. State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center,Sun Yat-Sen University,Guangzhou,China
- 折叠
摘要
关键词
apoptosis/BCL2L1(BCL-XL)/gastric cancer(GC)/PROTAC-BCL-XL/selective BCL-XL inhibitors分类
医药卫生引用本文复制引用
Yumin Wei,Liping Zhang,Chao Wang,Zefeng Li,Mingjie Luo,Guomin Xie,Xingjiu Yang,Mengyuan Li,Shuyue Ren,Dongbing Zhao,Ran Gao,Jia-Nan Gong..Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer[J].动物模型与实验医学(英文),2023,6(3):P.245-254,10.
